Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (381-390 of 632) with videos related to

Pageof 64
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphomaGeorg Feldmann, Hans Dieter Nischalke, Jacob Nattermann, et al.
Hepatology (Baltimore, Md.)|October 11, 2008
Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infectionMichael von Wagner, Wolf Peter Hofmann, Gerlinde Teuber, et al.
The Journal of Infectious Diseases|September 29, 2009
The HLA-E(R)/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-gamma-secreting human CD8(+) T cellsDaniela Schulte, Martin Vogel, Bettina Langhans, et al.
Journal of Viral Hepatitis|March 31, 2022
Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in GermanyTammo L Tergast, Sarah Blach, Frank Tacke, et al.
Journal of Viral Hepatitis|February 14, 2020
Serum hepatitis B virus RNA predicts response to peginterferon treatment in HBeAg-positive chronic hepatitis BMargo J H van Campenhout, Florian van Bömmel, Maria Pfefferkorn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 23, 2017
The effects of multi-disciplinary psycho-social care on socio-economic problems in cancer patients: a cluster-randomized trialSusanne Singer, Julia Roick, Jürgen Meixensberger, et al.
Journal of Hepatology|May 5, 2004
Combination therapy with amantadine and interferon in naïve patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trialsAlessandra Mangia, Gioacchino Leandro, Beat Helbling, et al.
Hepatology (Baltimore, Md.)|May 27, 2015
Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing propertiesRajiv G Tawar, Che C Colpitts, Jörg Timm, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 6, 2026
Radiologist-guided Analgosedation with Ketamine/Midazolam: A Feasible Strategy to Expand Percutaneous Tumor Ablation CapacityAnne Bettina Beeskow, Manuel Florian Struck, Aboelyazid Elkilany, et al.
Journal of Cancer Research and Clinical Oncology|June 18, 2025
Treatment with gemcitabine/cisplatin and durvalumab for advanced biliary tract cancer - real-world data from a multicenter German patient populationFlorian Gerhardt, Christian Müller, Marino Venerito, et al.
Pageof 64

Showing results (381-390 of 632) with videos related to

Sort By:
Pageof 64
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2006
Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphomaGeorg Feldmann, Hans Dieter Nischalke, Jacob Nattermann, et al.
Hepatology (Baltimore, Md.)|October 11, 2008
Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infectionMichael von Wagner, Wolf Peter Hofmann, Gerlinde Teuber, et al.
The Journal of Infectious Diseases|September 29, 2009
The HLA-E(R)/HLA-E(R) genotype affects the natural course of hepatitis C virus (HCV) infection and is associated with HLA-E-restricted recognition of an HCV-derived peptide by interferon-gamma-secreting human CD8(+) T cellsDaniela Schulte, Martin Vogel, Bettina Langhans, et al.
Journal of Viral Hepatitis|March 31, 2022
Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in GermanyTammo L Tergast, Sarah Blach, Frank Tacke, et al.
Journal of Viral Hepatitis|February 14, 2020
Serum hepatitis B virus RNA predicts response to peginterferon treatment in HBeAg-positive chronic hepatitis BMargo J H van Campenhout, Florian van Bömmel, Maria Pfefferkorn, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 23, 2017
The effects of multi-disciplinary psycho-social care on socio-economic problems in cancer patients: a cluster-randomized trialSusanne Singer, Julia Roick, Jürgen Meixensberger, et al.
Journal of Hepatology|May 5, 2004
Combination therapy with amantadine and interferon in naïve patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trialsAlessandra Mangia, Gioacchino Leandro, Beat Helbling, et al.
Hepatology (Baltimore, Md.)|May 27, 2015
Acute hepatitis C virus infection induces anti-host cell receptor antibodies with virus-neutralizing propertiesRajiv G Tawar, Che C Colpitts, Jörg Timm, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|February 6, 2026
Radiologist-guided Analgosedation with Ketamine/Midazolam: A Feasible Strategy to Expand Percutaneous Tumor Ablation CapacityAnne Bettina Beeskow, Manuel Florian Struck, Aboelyazid Elkilany, et al.
Journal of Cancer Research and Clinical Oncology|June 18, 2025
Treatment with gemcitabine/cisplatin and durvalumab for advanced biliary tract cancer - real-world data from a multicenter German patient populationFlorian Gerhardt, Christian Müller, Marino Venerito, et al.
Pageof 64